Suppr超能文献

接受血管内治疗患者的基因多态性与预后的关系

The Association between Genetic Polymorphism and Prognosis in Patients Receiving Endovascular Therapy.

作者信息

Li Wei, Yang Xun, Chen Jing, Zhu Jian-Wei, Zeng Ling-Huan, Long Hai-Hong, Chen Zhi, Tang Jun, Lan Xiao-Fang

机构信息

Department of Neurology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.

Department of Neurology, People's Hospital of Chongqing Hechuan, Chongqing, China.

出版信息

Ann Indian Acad Neurol. 2024 Jan-Feb;27(1):27-33. doi: 10.4103/aian.aian_564_23. Epub 2024 Feb 1.

Abstract

BACKGROUND

Potentially substantial impacts on the prognosis have been observed in individuals undergoing endovascular treatment due to cytochrome P450 2c19 (C) polymorphism. In an attempt to improve prognosis and lower the recurrence rate, this study investigated the polymorphism in acute ischemic stroke patients.

MATERIALS AND METHODS

A retrospective analysis was performed on 292 patients with cerebral infarction who had acute endovascular recanalization at the Department of Neurology of Chongqing Hospital of Traditional Chinese Medicine between May 2017 and 2019. The patients were categorized into rapid-, medium-, and slow-metabolism groups based on gene polymorphism, and their prognosis was monitored. In addition, the prognosis of 188 patients selectively receiving carotid artery stenting at a selected time was also observed.

RESULTS

Among the 292 cerebral infarction cases receiving acute endovascular recanalization, the patients in the rapid-metabolism group regularly took clopidogrel and aspirin combined with antiplatelet therapy and suffered from reoccurrence of apoplexy and cerebral hemorrhage; the 90-day good prognosis had a statistical difference ( < 0.05, prognostic assessment includes hospitalization and 6 months after discharge) and the other adverse events had no statistical difference (including mortality). The 188 patients selectively receiving carotid artery stenting had a recurrence of apoplexy, cerebral hemorrhage, and restenosis rate with a statistical difference ( < 0.05), and the other adverse events had no statistical difference.

CONCLUSIONS

In conclusion, the findings of the current study indicate that irrespective of whether patients are undergoing selective carotid artery stenting or acute endovascular recanalization, those with rapid metabolism have a significantly lower likelihood of experiencing adverse prognostic events compared to those with intermediate and slow metabolism. Furthermore, this group also has a more favorable prognosis than the other two groups.

摘要

背景

由于细胞色素P450 2c19(CYP2C19)基因多态性,接受血管内治疗的个体的预后可能受到重大影响。为了改善预后并降低复发率,本研究调查了急性缺血性中风患者的基因多态性。

材料与方法

对2017年5月至2019年期间在重庆市中医院神经内科接受急性血管内再通治疗的292例脑梗死患者进行回顾性分析。根据基因多态性将患者分为快代谢、中代谢和慢代谢组,并监测其预后。此外,还观察了188例在选定时间选择性接受颈动脉支架置入术的患者的预后。

结果

在292例接受急性血管内再通治疗的脑梗死病例中,快代谢组患者规律服用氯吡格雷和阿司匹林联合抗血小板治疗,发生中风复发和脑出血;90天良好预后有统计学差异(P<0.05,预后评估包括住院期间和出院后6个月),其他不良事件无统计学差异(包括死亡率)。188例选择性接受颈动脉支架置入术的患者发生中风复发、脑出血和再狭窄率有统计学差异(P<0.05),其他不良事件无统计学差异。

结论

总之,本研究结果表明,无论患者是接受选择性颈动脉支架置入术还是急性血管内再通治疗,快代谢患者与中代谢和慢代谢患者相比,发生不良预后事件的可能性显著降低。此外,该组的预后也比其他两组更有利。

相似文献

本文引用的文献

5
Incidence and Predictors of the In-stent Restenosis after Vertebral Artery Ostium Stenting.椎动脉开口支架置入术后支架内再狭窄的发生率及预测因素
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3030-3035. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.031. Epub 2018 Aug 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验